Antonie Giæver Beiske

ω-3 Fatty Acid Treatment in Multiple Sclerosis (OFAMS Study)

Øivind Torkildsen, Stig Wergeland, S. J. Bakke et al. · Archives of Neurology · 2012 · 149 citations

Life Sciences, Neurology, Pharmacotherapy +15

Vitamin D and disease activity in multiple sclerosis before and during interferon-β treatment

Kristin I. Løken-Amsrud, Trygve Holmøy, S. J. Bakke et al. · Neurology · 2012 · 107 citations

Medicine, Neurology, Pharmacotherapy +17

NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial

Per Soelberg Sørensen, Svein Ivar Mellgren, Anders Svenningsson et al. · The Lancet Neurology · 2009 · 100 citations

Life Sciences, Neurology, Pharmacotherapy +14

Body mass index influence interferon-beta treatment response in multiple sclerosis

Silje Stokke Kvistad, Kjell‐Morten Myhr, Trygve Holmøy et al. · Journal of Neuroimmunology · 2015 · 67 citations

Life Sciences, Immunology, Neurology +11

Antibodies to Epstein-Barr virus and MRI disease activity in multiple sclerosis

Silje Stokke Kvistad, Kjell‐Morten Myhr, Trygve Holmøy et al. · Multiple Sclerosis Journal · 2014 · 67 citations

Life Sciences, Immunology, Neurology +12